In such a dynamic healthcare landscape with technological disruption at various stages, the pace of change is high and the pressure for highly reliable and cost effective healthcare delivery is on. Thus, the need to create one common platform to bring all the concerned stakeholders to discuss, collaborate and understand best practices, experiment with new methods and tools, and learn essential skills. Recent advances in injectable biologics and smart medical devices has led to an increase in novel approaches to treating severe asthma and COPD as well as the regulations to take into consideration. As technology soars, the need for guideline updates from regulators has increased and continues to be modified.With asthma and chronic obstructive pulmonary disorder (COPD) affecting about 500 million people worldwide, opportunities in the treatment and drug development are vast, reducing serious attacks by improving patient condition and saving healthcare costs.The 3rd Annual Dubai International Asthma, Allergy & COPD Forum taking place on 04 – 05 October 2019, is a unique platform to bring together the C-suite level, senior executives and decision makers in the hospitals, leading pulmonologists, technology and solutions providers, regulators and policy makers, R&D and academics to discuss the latest treatment modalities, sharing case-based studies and challenges in the practice, while focusing on many novel techniques, modern updates in lung research fields and clinical-based topics.